226 related articles for article (PubMed ID: 25742469)
1. ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels.
Rondeau S; Vacher S; De Koning L; Briaux A; Schnitzler A; Chemlali W; Callens C; Lidereau R; Bièche I
Br J Cancer; 2015 Mar; 112(6):1059-66. PubMed ID: 25742469
[TBL] [Abstract][Full Text] [Related]
2. ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas.
Bueno RC; Canevari RA; Villacis RA; Domingues MA; Caldeira JR; Rocha RM; Drigo SA; Rogatto SR
Ann Oncol; 2014 Jan; 25(1):69-75. PubMed ID: 24285016
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN.
Beggs AD; Domingo E; McGregor M; Presz M; Johnstone E; Midgley R; Kerr D; Oukrif D; Novelli M; Abulafi M; Hodgson SV; Fadhil W; Ilyas M; Tomlinson IP
Oncotarget; 2012 Nov; 3(11):1348-55. PubMed ID: 23154512
[TBL] [Abstract][Full Text] [Related]
4. Hsp90α regulates ATM and NBN functions in sensing and repair of DNA double-strand breaks.
Pennisi R; Antoccia A; Leone S; Ascenzi P; di Masi A
FEBS J; 2017 Aug; 284(15):2378-2395. PubMed ID: 28631426
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
[TBL] [Abstract][Full Text] [Related]
6. Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma.
Mansour WY; Bogdanova NV; Kasten-Pisula U; Rieckmann T; Köcher S; Borgmann K; Baumann M; Krause M; Petersen C; Hu H; Gatti RA; Dikomey E; Dörk T; Dahm-Daphi J
Radiother Oncol; 2013 Jan; 106(1):147-54. PubMed ID: 23199656
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer.
Wu CW; Dong YJ; Liang QY; He XQ; Ng SS; Chan FK; Sung JJ; Yu J
PLoS One; 2013; 8(2):e57036. PubMed ID: 23437304
[TBL] [Abstract][Full Text] [Related]
8. Lower ataxia telangiectasia mutated (ATM) mRNA expression is correlated with poor outcome of laryngeal and pharyngeal cancer patients.
Lee KW; Tsai YS; Chiang FY; Huang JL; Ho KY; Yang YH; Kuo WR; Chen MK; Lin CS
Ann Oncol; 2011 May; 22(5):1088-1093. PubMed ID: 21127011
[TBL] [Abstract][Full Text] [Related]
9. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase.
Song L; Lin C; Wu Z; Gong H; Zeng Y; Wu J; Li M; Li J
PLoS One; 2011; 6(9):e25454. PubMed ID: 21980462
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.
Hallajian Z; Mahjoubi F; Nafissi N
Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
[TBL] [Abstract][Full Text] [Related]
12. ATM-mediated DNA double-strand break response facilitated oncolytic Newcastle disease virus replication and promoted syncytium formation in tumor cells.
Ren S; Ur Rehman Z; Gao B; Yang Z; Zhou J; Meng C; Song C; Nair V; Sun Y; Ding C
PLoS Pathog; 2020 Jun; 16(6):e1008514. PubMed ID: 32479542
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide excision repair-dependent DNA double-strand break formation and ATM signaling activation in mammalian quiescent cells.
Wakasugi M; Sasaki T; Matsumoto M; Nagaoka M; Inoue K; Inobe M; Horibata K; Tanaka K; Matsunaga T
J Biol Chem; 2014 Oct; 289(41):28730-7. PubMed ID: 25164823
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic Analysis of ATM Protein Kinase in DNA Double-Strand Break Formation and Repair.
Mian E; Wiesmüller L
Methods Mol Biol; 2017; 1599():317-334. PubMed ID: 28477129
[TBL] [Abstract][Full Text] [Related]
15. Localization of Double-Strand Break Repair Proteins to Viral Replication Compartments following Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Hollingworth R; Horniblow RD; Forrest C; Stewart GS; Grand RJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28855246
[TBL] [Abstract][Full Text] [Related]
16. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade.
Ding SL; Sheu LF; Yu JC; Yang TL; Chen BF; Leu FJ; Shen CY
Br J Cancer; 2004 May; 90(10):1995-2001. PubMed ID: 15138484
[TBL] [Abstract][Full Text] [Related]
17. Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer.
Feng X; Li H; Dean M; Wilson HE; Kornaga E; Enwere EK; Tang P; Paterson A; Lees-Miller SP; Magliocco AM; Bebb G
Breast Cancer Res; 2015 May; 17(1):65. PubMed ID: 25935535
[TBL] [Abstract][Full Text] [Related]
18. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
[TBL] [Abstract][Full Text] [Related]
19. ATP puts the brake on DNA double-strand break repair: a new study shows that ATP switches the Mre11-Rad50-Nbs1 repair factor between signaling and processing of DNA ends.
Hopfner KP
Bioessays; 2014 Dec; 36(12):1170-8. PubMed ID: 25213441
[TBL] [Abstract][Full Text] [Related]
20. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.
Albarakati N; Abdel-Fatah TM; Doherty R; Russell R; Agarwal D; Moseley P; Perry C; Arora A; Alsubhi N; Seedhouse C; Rakha EA; Green A; Ball G; Chan S; Caldas C; Ellis IO; Madhusudan S
Mol Oncol; 2015 Jan; 9(1):204-17. PubMed ID: 25205036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
